13F 机构持仓

a16z Capital Management, L.L.C.

MENLO PARK CA · SEC CIK 0001540358

2026Q22026Q1 更早 9 个季度 🔒
$12.91亿2026Q1 申报市值
16持仓数
96.0%前十大占比 · 第一大 28.9%
4 / 1新建仓 / 清仓
申报市值走势$142.15亿2026Q2
26Q126Q2

付费方案可看全部 11 个季度的走势 🔒

前十大持仓 占组合比例

NAVN 28.9%
FIG 26.2%
META 9.4%
RVMD 6.9%
NAUTILUS BIOTE 5.3%
XYZ 4.7%
BIOA 4.4%
MAZE 3.9%
ERAS 3.6%
DMRA 2.5%

2026Q1 买入最多 按季末市值估算

DMRA 新建仓+$3,201.65万
NAVN 加仓+$1,354.87万
AKTS 新建仓+$742.43万
BTGO 新建仓+$548.41万
IP STRATEGY HOLD 新建仓+$2.18万

2026Q1 卖出最多 按季末市值估算

OMDA 减仓-$1,450.13万
FIG 减仓-$496.26万
HERITAGE COMM CO 清仓-$99.37万

2026Q1 持仓明细 点表头排序

导出 CSV 🔒
代码名称市值 ▼占比股数变动股数变动估算买卖额操作
NAVN NAVAN INC $3.74亿28.95%28,218,676 1,023,3123.8% $1,354.87万 加仓
FIG FIGMA INC $3.38亿26.23%16,011,378 -234,751-1.4% -$496.26万 减仓
META META PLATFORMS INC $1.22亿9.42%212,531 00.0% — 不变
RVMD REVOLUTION MEDICINES INC $8,957.69万6.94%921,099 00.0% — 不变
— NAUTILUS BIOTECHNOLOGY INC $6,849.72万5.31%17,653,917 00.0% — 不变
XYZ BLOCK INC $6,118.48万4.74%1,016,697 00.0% — 不变
BIOA BIOAGE LABS INC $5,654.81万4.38%3,233,170 00.0% — 不变
MAZE MAZE THERAPEUTICS INC $5,081.14万3.94%1,702,225 00.0% — 不变
ERAS ERASCA INC $4,631.52万3.59%2,862,500 00.0% — 不变
DMRA DAMORA THERAPEUTICS INC $3,201.65万2.48%1,236,157 1,236,157— $3,201.65万 新建仓
OMDA OMADA HEALTH INC $2,900.26万2.25%2,307,284 -1,153,645-33.3% -$1,450.13万 减仓
CAMP CAMP4 THERAPEUTICS CORP $937.27万0.73%2,125,339 00.0% — 不变
AKTS AKTIS ONCOLOGY INC $742.43万0.58%415,000 415,000— $742.43万 新建仓
BTGO BITGO HOLDINGS INC $548.41万0.42%666,356 666,356— $548.41万 新建仓
DNA GINKGO BIOWORKS HOLDINGS INC $66.55万0.05%108,568 00.0% — 不变
— IP STRATEGY HOLDINGS INC $2.18万0.00%82,740 82,740— $2.18万 新建仓
— HERITAGE COMM CORP $00.00%0 -82,740-100.0% -$99.37万 清仓